Pith. sign in

REVIEW 4 major objections 5 minor 25 references

ADAgent: LLM Agent for Alzheimer's Disease Analysis with Collaborative Coordinator

T0 review · 4 major / 5 minor · reviewed 2026-08-07 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

Pith's one-line read ADAgent, an LLM-based agent that coordinates specialized medical tools, reports accuracy gains up to 4.4% over existing Alzheimer's diagnosis methods.

desk verdict Plausible LLM-agent wrapper for AD imaging with small, shaky gains; the duplicated PET row in Table 3 undercuts the ablation claims, but the idea is worth a referee. read the letter →

arxiv 2506.11150 v3 pith:TBV367OX submitted 2025-06-11 eess.IV cs.CV

Wenlong Hou , Guangqian Yang , Ye Du , Yeung Lau , Lihao Liu , Junjun He , Ling Long , Shujun Wang This is my paper
classification eess.IVcs.CV
keywords Alzheimer'sdiseaselargelanguagemodelAIagentmulti-modaldiagnosismissingmodalitycollaborationprognosismedicalimageanalysis
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

Alzheimer's disease is hard to diagnose from a single brain scan, and existing multi-modal deep-learning systems are locked to fixed input combinations. This paper proposes ADAgent, a large-language-model (LLM) based agent that plans which medical tools to run and then reads all their outputs to make a final call. The central claim is that this LLM-coordinated ensemble beats both every individual model and simple aggregation rules, with reported accuracy gains of 2.7% on multi-modal diagnosis, 0.7% on prognosis, and 0.7% or 4.4% on MRI-only and PET-only diagnosis. If true, it would mean hospitals could upgrade existing diagnostic models into a flexible, extensible system without retraining, and handle missing scans gracefully.

What carries the argument

The load-bearing mechanism is the Collaborative Outcome Coordinator, the function $R = C(O_1(M_1), \dots, O_n(M_n))$ that fuses the outputs of several tool-embedded models through LLM reasoning. Around it runs a four-stage loop — Observation, Thought, Action, Coordinator — adapted from a medical reasoning agent, which lets the system decide which tools are relevant for a given query and, when a modality is missing, fall back to the single-modality tool that is available. The coordinator is what transforms a set of independent classifiers into a deliberative ensemble.

What would settle it

Take the same tool outputs and replace the LLM coordinator with a weighted average whose weights are fitted on a validation set, while shuffling the order of the per-model probability vectors and removing model names; if this simple aggregator matches or beats ADAgent's accuracy, the specific claim that LLM reasoning drives the improvement is falsified.

Watch

Extended reading notes

Core claim

On its own terms, the paper's discovery is that LLM reasoning can serve as a model-collaboration layer for medical imaging. ADAgent wraps multiple existing classification models as tools; for a query the agent observes the request, decides which tools to call, executes them, and then hands their per-class probability vectors to a Collaborative Outcome Coordinator. That coordinator, implemented in the LLM, interprets agreements and disagreements among the models and issues a single diagnosis or prognosis. In experiments on a public Alzheimer's cohort, the agent outperformed all five individual models on multi-modal diagnosis and prognosis, and outperformed both averaging and majority-vote baselines on every task, with the largest edge on PET-only diagnosis (4.4% accuracy). The authors take this as evidence that the LLM's reasoning over model outputs, not just the underlying models' power, drives the improvement.

Load-bearing premise

The paper's central claim depends on the assumption that the LLM coordinator improves over simple aggregation by genuinely reasoning about complementary model outputs; if the models are redundant or the LLM exploits superficial patterns in how outputs are presented, the reported gains will not generalise.

Editorial extensions

If this is right

  • Existing single-modality diagnostic models can be combined into a multi-modal system without retraining any of them.
  • Adding a new modality or task reduces to writing a class definition for a new tool, so the same agent could extend to other neurodegenerative diseases.
  • Missing-modality scenarios, common in clinical practice, are handled by the same framework because the agent falls back to whichever single-modality tools are available.
  • The consistent edge over averaging and voting baselines suggests that reasoning over model disagreements, not just probability pooling, is where the value lies.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The coordinator's advantage may depend on model diversity; if the tools share the same training data or biases, the reasoning layer may have nothing useful to reconcile, so the gains could shrink.
  • A practical extension would be to have the coordinator flag high-disagreement cases for human review, turning the agent into a triage tool rather than only a classifier.
  • The same collaborative-coordination pattern could transfer to other multi-modal medical tasks, such as chest imaging combined with electronic health records, if the underlying models are sufficiently independent.
  • One testable refinement is to make the coordinator base decisions on feature-level evidence, such as atrophy location, rather than probability vectors alone, which would also make aggregation auditable.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 5 minor

Summary. The paper presents ADAgent, an LLM-based agent for Alzheimer's disease (AD) analysis that combines a reasoning engine, task-specific medical tools, and a collaborative outcome coordinator. The coordinator receives predictions from multiple existing models (e.g., CMViM, MCAD, nnMamba, MedicalNet, ResNet variants) and uses GPT-4o to produce a final diagnosis or prognosis. Experiments on the ADNI dataset cover multi-modal diagnosis, multi-modal prognosis, and missing-modality (MRI-only, PET-only) diagnosis, with comparisons against individual baselines and two simple aggregation baselines (Average and Vote). The paper claims accuracy improvements of 2.7% (multi-modal diagnosis), 0.7% (multi-modal prognosis), 0.7% (MRI diagnosis), and 4.4% (PET diagnosis), and argues that the LLM coordinator improves over naive aggregation.

Significance. If the reported effects are real and reproducible, ADAgent would be a useful contribution to medical imaging agents: it offers a modular, extensible way to integrate multiple task-specific models without additional training, and it addresses realistic missing-modality scenarios. The paper's strengths include the explicit modular architecture, the attempt to compare against Average and Vote baselines, and the use of a real clinical dataset (ADNI). However, the significance is currently limited by the small scale of the evaluation (three runs, ADNI only), the lack of statistical significance testing, and the unresolved question of whether gains come from genuine reasoning or from incidental cues such as model names and output ordering. The internal inconsistency in Table 3 further weakens the ablation evidence, so the central claim is plausible but not yet convincingly supported.

major comments (4)
  1. [Table 3 / Section 3.3] Table 3 contains a load-bearing internal inconsistency: the ADAgent row for the PET diagnosis task reports ACC 0.644, SPE 0.794, SEN 0.644, F1 0.647, which is exactly the same as the ADAgent row for the multi-modal diagnosis task, while Table 2 reports the PET diagnosis results for ADAgent as ACC 0.594, SPE 0.785, SEN 0.631, F1 0.611. Because Table 3 is the only ablation evidence for the PET diagnosis task, this duplication invalidates the PET ablation and the corresponding claim of a 4.4% PET improvement. The authors should correct this error and re-run or re-report the PET ablation.
  2. [Tables 1 and 2 / Section 3.2] The reported improvements over the best baselines are often within overlapping standard deviations with only three runs, and no paired or per-subject significance tests are provided. For example, multi-modal diagnosis accuracy is 0.644±0.014 for ADAgent versus 0.617±0.014 for CMViM; multi-modal prognosis accuracy is 0.822±0.010 versus 0.815±0.046; and MRI diagnosis accuracy is 0.543±0.007 versus 0.536±0.012 for ResNet50. The paper should provide statistical tests (e.g., paired bootstrap or McNemar-style tests on the test subjects) or otherwise demonstrate that the differences are not noise, especially for the comparisons against Average and Vote in Table 3.
  3. [Section 2.2 / Figure 2 / Section 3.3] The coordinator's advantage is attributed to the LLM's reasoning over model outputs, but the prompt is not released and the example in Figure 2 shows model names such as CMViM and nnMamba being passed to GPT-4o. The only ablation controls are Average and Vote, which do not control for the LLM's prior beliefs about model names or for output ordering. The authors should test whether the gains persist when model identities are masked, when output order is shuffled, and when the same LLM is given the outputs in a different format; they should also release the coordinator prompt to make the mechanism reproducible.
  4. [Section 2.2, Eq. (4)] The collaborative outcome coordinator is defined only symbolically as R = C(O1(M1), O2(M2), ..., On(Mn)); the manuscript does not specify the prompt structure, the number of LLM calls, the temperature, or how contradictory or low-confidence outputs are handled. Since this module is the central novelty, the lack of detail prevents independent implementation and makes it difficult to separate the coordinator's design from the choice of GPT-4o as the backbone. Please provide the full coordinator prompt (or a precise pseudocode) and report sensitivity to the LLM backbone.
minor comments (5)
  1. [Section 3 / Section 3.3] The phrase "To access the performance" should be "To assess the performance".
  2. [Figure 1] The label "Intend Analysis" should be "Intent Analysis", and the text elsewhere says "use query" and "use input" where "user query" and "user input" are intended.
  3. [Table 1] The citation for CMViM is given as [18], but reference [18] is an EEG self-attention paper; the CMViM method is cited as [21] in the reference list. Please correct the citation.
  4. [Figure 2] In the tool output, "0.999O" appears to be a typo for "0.9990".
  5. [Section 3.1] The dataset section does not describe the train/validation/test split, preprocessing details, or how the three experimental runs differ; these details are needed for reproducibility.

Circularity Check

1 steps flagged · score 4.0 of 10

One headline gain is a re-labeled copy rather than a measurement: Table 3's PET diagnosis row is numerically identical to the multi-modal diagnosis row, so the 4.4% PET improvement reduces to a different task's result; the remaining gains are independent empirical ensemble results, with only minor same-group citations.

  1. other [Section 3.3 'Ablation Study', Table 3, PET diagnosis block vs. multi-modality diagnosis block; compare Tables 1 and 2.]
    "Method ACC SPE SEN F1 ACC SPE SEN F1 ... Multi-modality Diagnosis task Prognosis task ... ADAgent (Ours) 0.644 0.794 0.644 0.647 0.822 0.941 0.545 0.561 ... Missing Modality MRI diagnosis task PET diagnosis task ... ADAgent (Ours) 0.543 0.754 0.561 0.553 0.644 0.794 0.644 0.647"

    The PET diagnosis ablation row for ADAgent (0.644 / 0.794 / 0.644 / 0.647) is numerically identical, cell for cell, to the multi-modality diagnosis ADAgent row in the same table and to the Table 1 multi-modal diagnosis row (0.644 ±0.014 / 0.794 ±0.010 / 0.644 ±0.021 / 0.647 ±0.018), yet it does not match ADAgent's own PET row in Table 2 (0.594 / 0.785 / 0.631 / 0.611). The abstract and Section 3.3 credit a 4.4% PET improvement, but the ablation evidence is not a PET-specific measurement; it is the multi-modal diagnosis result re-labeled as PET. The PET gain reduces by identity to another task's outcome.

full rationale

ADAgent contains no mathematical derivation chain whose outputs could equal its inputs: Eqs. (1)-(4) define the tasks and the coordinator function C, and the headline numbers are measured evaluation scores, not quantities derived from a fitted model. The same trained models (MedicalNet, nnMamba, ResNet50, MCAD, CMViM) appear both as baselines and as tools inside the agent; that is a standard ensemble comparison, not circular reasoning, and the LLM coordinator is not trained on the test data, so no fitted parameter is renamed as a prediction. Same-group citations exist (CMViM [21] shares authors; HGiB [19] shares an author), but they are used as empirically measured baselines and integrated tools, not as premises that force the result, so they are not load-bearing. The one concrete, exhibit-able reduction is in Table 3: the PET diagnosis ADAgent row (0.644 / 0.794 / 0.644 / 0.647) is identical to the multi-modality diagnosis ADAgent row in the same table and in Table 1, while Table 2's own PET row is different (0.594 / 0.785 / 0.631 / 0.611). The claimed 4.4% PET improvement therefore rests on a re-labeled copy of the multi-modal result rather than on a distinct PET-specific measurement, which is a partial circularity affecting one of the four headline gains. The multi-modal diagnosis (2.7%), prognosis (0.7%), and MRI (0.7%) claims rest on distinct numbers and would stand on their own, so the central claim is not forced by construction.

Assumptions & free parameters 0 free parameters · 2 assumptions · 0 invented entities

The system reuses existing models and a frozen LLM; no new numbers are fitted to data in this paper. The central claim relies on the completeness of the ADNI evaluation and on the LLM's aggregation ability.

assumptions (2)
  • domain assumption ADNI dataset is representative of clinical AD populations for diagnosis and prognosis.
    The paper evaluates only on ADNI (Section 3.1) and generalizes conclusions to AD analysis without external validation.
  • domain assumption GPT-4o can aggregate model outputs more effectively than averaging or voting.
    The collaborative outcome coordinator (Section 2.2) uses the LLM as a judge; no independent evidence is provided that this aggregation is reliable across tasks.

how reviews work

0 comments
Cite this review

Pith. "Pith review of ADAgent: LLM Agent for Alzheimer's Disease Analysis with Collaborative Coordinator." pith.science (2026). https://pith.science/paper/TBV367OX

@misc{pith2026250611150,
  author       = {Pith},
  title        = {Pith review of: ADAgent: LLM Agent for Alzheimer's Disease Analysis with Collaborative Coordinator},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/TBV367OX}},
  note         = {Machine review of arXiv:2506.11150}
}
read the original abstract

Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disease. Early and precise diagnosis of AD is crucial for timely intervention and treatment planning to alleviate the progressive neurodegeneration. However, most existing methods rely on single-modality data, which contrasts with the multifaceted approach used by medical experts. While some deep learning approaches process multi-modal data, they are limited to specific tasks with a small set of input modalities and cannot handle arbitrary combinations. This highlights the need for a system that can address diverse AD-related tasks, process multi-modal or missing input, and integrate multiple advanced methods for improved performance. In this paper, we propose ADAgent, the first specialized AI agent for AD analysis, built on a large language model (LLM) to address user queries and support decision-making. ADAgent integrates a reasoning engine, specialized medical tools, and a collaborative outcome coordinator to facilitate multi-modal diagnosis and prognosis tasks in AD. Extensive experiments demonstrate that ADAgent outperforms SOTA methods, achieving significant improvements in accuracy, including a 2.7% increase in multi-modal diagnosis, a 0.7% improvement in multi-modal prognosis, and enhancements in MRI and PET diagnosis tasks.

Figures

Figures reproduced from arXiv: 2506.11150 by the authors.

Figure 1
Figure 1. Overall workflow of ADAgent. Given a use query, the framework per￾forms reasoning in four stages: (i) observation, (ii) thought, (iii) action, and (iv) collaborative outcome coordinator. prognosis of AD. ADAgent can be extended to more tasks by accessing more tools/methods seamlessly without extra training. To access the performance of the proposed ADAgent, we extensively compared the result of ADAgent against multi… view at source ↗
Figure 2
Figure 2. ADAgent Interaction Example. An example of how ADAgent handles a conversation through its workflow (<thought>, <action>, <Tool>) along with tool outputs and final response. Similarly, if only the PET modality is available, the PET Diagnosis Tool TPET is used to process XPET and make predictions. Although ADAgent currently integrates existing tools for AD diagnosis and prognosis, its architecture is highly extensible… view at source ↗

Discussion (0). Sign in to comment.

Reference graph

Works this paper leans on

25 extracted references · 18 canonical work pages

  1. [1]

    Artificial intelligence in medicine 71, 1–29 (2016)

    Alberdi, A., Aztiria, A., Basarab, A.: On the early diagnosis of alzheimer’s disease from multimodal signals: A survey. Artificial intelligence in medicine 71, 1–29 (2016)

    work page 2016

  2. [2]

    Alzheimers Dement 19(4), 1598–1695 (2023)

    Better, M.A.: Alzheimer’s disease facts and figures. Alzheimers Dement 19(4), 1598–1695 (2023)

    work page 2023

  3. [3]

    arXiv preprint arXiv:1904.00625 (2019)

    Chen, S., Ma, K., Zheng, Y.: Med3d: Transfer learning for 3d medical image anal- ysis. arXiv preprint arXiv:1904.00625 (2019)

    arXiv 2019

  4. [4]

    Cui, R., Liu, M.: Hippocampus analysis by combination of 3-d densenet and shapes foralzheimer’sdiseasediagnosis.IEEEjournalofbiomedicalandhealthinformatics 23(5), 2099–2107 (2018)

    work page 2018

  5. [5]

    The Lancet Neurology 20(6), 484–496 (2021)

    Dubois, B., Villain, N., Frisoni, G.B., Rabinovici, G.D., Sabbagh, M., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., et al.: Clinical diagnosis of alzheimer’s disease: recommendations of the international working group. The Lancet Neurology 20(6), 484–496 (2021)

    work page 2021

  6. [6]

    Fallahpour, A., Ma, J., Munim, A., Lyu, H., Wang, B.: Medrax: Medical reasoning agent for chest x-ray (2025),https://arxiv.org/abs/2502.02673

    arXiv 2025

  7. [7]

    Gong, H., Kang, L., Wang, Y., Wan, X., Li, H.: nnmamba: 3d biomedical image segmentation, classification and landmark detection with state space model (2024), https://arxiv.org/abs/2402.03526

    arXiv 2024

  8. [8]

    He,K.,Zhang,X.,Ren,S.,Sun,J.:Deepresiduallearningforimagerecognition.In: Proceedings of the IEEE conference on computer vision and pattern recognition. pp. 770–778 (2016)

    2016

Show all 25 references
  1. [9]

    Frontiers in Aging Neuroscience15, 1102869 (2023)

    Hoang, G.M., Kim, U.H., Kim, J.G.: Vision transformers for the prediction of mild cognitive impairment to alzheimer’s disease progression using mid-sagittal smri. Frontiers in Aging Neuroscience15, 1102869 (2023)

    2023

  2. [10]

    IEEE Journal of Biomedical and Health Informatics (2024)

    Huang, F., Qiu, A., Initiative, A.D.N., et al.: Ensemble vision transformer for dementia diagnosis. IEEE Journal of Biomedical and Health Informatics (2024)

    2024

  3. [11]

    bmj367 (2019) 10 W

    Joe, E., Ringman, J.M.: Cognitive symptoms of alzheimer’s disease: clinical man- agement and prevention. bmj367 (2019) 10 W. Hou et al

    2019

  4. [12]

    arXiv preprint arXiv:2407.02483 (2024)

    Li, B., Yan, T., Pan, Y., Luo, J., Ji, R., Ding, J., Xu, Z., Liu, S., Dong, H., Lin, Z., et al.: Mmedagent: Learning to use medical tools with multi-modal agent. arXiv preprint arXiv:2407.02483 (2024)

    2024 arXiv

  5. [13]

    IEEE transactions on pattern analysis and machine intelligence42(4), 880–893 (2018)

    Lian, C., Liu, M., Zhang, J., Shen, D.: Hierarchical fully convolutional network for joint atrophy localization and alzheimer’s disease diagnosis using structural mri. IEEE transactions on pattern analysis and machine intelligence42(4), 880–893 (2018)

    2018

  6. [14]

    IEEE transactions on medical imaging39(3), 718–728 (2019)

    Liu, L., Dou, Q., Chen, H., Qin, J., Heng, P.A.: Multi-task deep model with margin ranking loss for lung nodule analysis. IEEE transactions on medical imaging39(3), 718–728 (2019)

    2019

  7. [15]

    In: Annual Conference on Medical Image Understanding and Analysis

    Liu, L., Hong, C., Aviles-Rivero, A.I., Schönlieb, C.B.: Simultaneous semantic and instance segmentation for colon nuclei identification and counting. In: Annual Conference on Medical Image Understanding and Analysis. pp. 130–138. Springer (2022)

    2022

  8. [16]

    Organization, W.H., et al.: Global status report on the public health response to dementia (2021)

    2021

  9. [17]

    The Lancet 397(10284), 1577–1590 (2021)

    Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunis- sen, C.E., Cummings, J., van der Flier, W.M.: Alzheimer’s disease. The Lancet 397(10284), 1577–1590 (2021)

    2021

  10. [18]

    IEEE Journal of Biomedical and Health Informatics (2024)

    Sibilano, E., Buongiorno, D., Lassi, M., Grippo, A., Bessi, V., Sorbi, S., Mazzoni, A., Bevilacqua, V., Brunetti, A.: Understanding the role of self-attention in a transformer model for the discrimination of scd from mci using resting-state eeg. IEEE Journal of Biomedical and ...

    2024

  11. [19]

    arXiv preprint arXiv:2303.10390 (2023)

    Wang, S., Aviles-Rivero, A.I., Kourtzi, Z., Schönlieb, C.B.: Hgib: Prognosis for alzheimer’s disease via hypergraph information bottleneck. arXiv preprint arXiv:2303.10390 (2023)

    2023

  12. [20]

    Alzheimer’s & Dementia 9(5), e111–e194 (2013)

    Weiner, M.W., Veitch, D.P., Aisen, P.S., Beckett, L.A., Cairns, N.J., Green, R.C., Harvey, D., Jack, C.R., Jagust, W., Liu, E., et al.: The alzheimer’s disease neu- roimaging initiative: a review of papers published since its inception. Alzheimer’s & Dementia 9(5), e111–e194 (2013)

    2013

  13. [21]

    arXiv preprint arXiv:2403.16520 (2024)

    Yang, G., Du, K., Yang, Z., Du, Y., Zheng, Y., Wang, S.: Cmvim: Contrastive masked vim autoencoder for 3d multi-modal representation learning for ad classi- fication. arXiv preprint arXiv:2403.16520 (2024)

    2024 arXiv

  14. [22]

    Computers in Biology and Medicine180, 108979 (2024)

    Yu, Q., Ma, Q., Da, L., Li, J., Wang, M., Xu, A., Li, Z., Li, W., Initiative, A.D.N., et al.: A transformer-based unified multimodal framework for alzheimer’s disease assessment. Computers in Biology and Medicine180, 108979 (2024)

    2024

  15. [23]

    Computers in Biology and Medicine 162, 107050 (05 2023)

    Zhang, J., He, X., Liu, Y., Cai, Q., Chen, H., Qing, L.: Multi-modal cross-attention network for alzheimer’s disease diagnosis with multi-modality data. Computers in Biology and Medicine 162, 107050 (05 2023). https://doi.org/10.1016/j. compbiomed.2023.107050

    2023

  16. [24]

    IEEE journal of biomedical and health informatics 26(11), 5289–5297 (2021)

    Zhang, X., Han, L., Zhu, W., Sun, L., Zhang, D.: An explainable 3d residual self- attention deep neural network for joint atrophy localization and alzheimer’s disease diagnosis using structural mri. IEEE journal of biomedical and health informatics 26(11), 5289–5297 (2021)

    2021

  17. [25]

    Journal of neuroscience methods 365, 109376 (2022)

    Zhang, Y., Teng, Q., Liu, Y., Liu, Y., He, X.: Diagnosis of alzheimer’s disease based on regional attention with smri gray matter slices. Journal of neuroscience methods 365, 109376 (2022)

    2022

Pith tools

Reviewed August 7, 2026 · model on record in the stance chip above.